(TCAF) T. Rowe Price - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US87283Q8675 • Large Blend

TCAF: Large, Cap, Equity, U.S.,Blend

T. Rowe Price Exchange-Traded Funds, Inc. (NYSE ARCA:TCAF) is an exchange-traded fund designed to provide exposure to equity securities, with a primary focus on large U.S. companies. The fund typically allocates at least 80% of its net assets to equity investments, which may include common stocks of businesses spanning various market capitalizations. While it maintains flexibility to invest in companies of any size, its portfolio is predominantly composed of large-cap U.S. equities. The fund is non-diversified, meaning it may concentrate its holdings in certain sectors or industries. Historically, it has shown significant exposure to the information technology and healthcare sectors, which are key drivers of innovation and growth in the U.S. economy.

From a technical perspective, TCAF has shown a recent price of $31.81, with a 20-day average volume of 1,395,050 shares. Its short-term moving average (SMA 20) is $31.02, while its medium-term (SMA 50) and long-term (SMA 200) averages are $32.30 and $32.84, respectively. This indicates a slight dip in the short term but overall stability in the longer term. The Average True Range (ATR) of 0.85 suggests moderate volatility. The funds assets under management (AUM) stand at $3,754.17 million, reflecting its popularity among investors seeking large-cap exposure.

Over the next three months, TCAF is expected to remain stable, with potential upside driven by its heavy exposure to information technology and healthcare sectors. The SMA 50 and SMA 200, both above the current price, suggest a bullish long-term trend. However, the recent dip below the SMA 20 could indicate short-term weakness. Support levels may emerge near $31.02, while resistance could be tested at $32.84. The ATR of 0.85 implies that price fluctuations will likely remain contained, with average daily price movements expected to stay within a narrow range.

From a fundamental perspective, the funds AUM of $3,754.17 million underscores its liquidity and investor confidence. Large U.S. companies, particularly in the technology and healthcare sectors, are expected to continue their growth trajectory, supported by strong earnings and innovation. However, macroeconomic factors such as interest rate changes and sector rotation could impact performance. Investors should monitor sector weightings and broader market trends to assess potential risks and opportunities.

Additional Sources for TCAF ETF

TCAF ETF Overview

Market Cap in USD 3,754m
Category Large Blend
TER 0.31%
IPO / Inception 2023-06-14

TCAF ETF Ratings

Growth Rating 47.6
Fundamental -
Dividend Rating 49.0
Rel. Strength -1.66
Analysts -
Fair Price Momentum 28.01 USD
Fair Price DCF -

TCAF Dividends

Dividend Yield 12m 0.45%
Yield on Cost 5y 0.57%
Annual Growth 5y 42.91%
Payout Consistency 100.0%

TCAF Growth Ratios

Growth Correlation 3m -90.5%
Growth Correlation 12m 52.8%
Growth Correlation 5y 90.7%
CAGR 5y 13.22%
CAGR/Max DD 5y 0.81
Sharpe Ratio 12m 1.10
Alpha -0.91
Beta 0.877
Volatility 29.47%
Current Volume 1205.9k
Average Volume 20d 1395.1k
What is the price of TCAF stocks?
As of May 01, 2025, the stock is trading at USD 32.02 with a total of 1,205,853 shares traded.
Over the past week, the price has changed by +3.49%, over one month by -0.81%, over three months by -7.00% and over the past year by +10.02%.
Is T. Rowe Price a good stock to buy?
Partly, yes. Based on ValueRay Analyses, T. Rowe Price (NYSE ARCA:TCAF) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 47.59 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TCAF as of May 2025 is 28.01. This means that TCAF is currently overvalued and has a potential downside of -12.52%.
Is TCAF a buy, sell or hold?
T. Rowe Price has no consensus analysts rating.
What are the forecast for TCAF stock price target?
According to ValueRays Forecast Model, TCAF T. Rowe Price will be worth about 31.9 in May 2026. The stock is currently trading at 32.02. This means that the stock has a potential downside of -0.34%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 31.9 -0.3%